Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Urol. Jul 24, 2014; 3(2): 87-95
Published online Jul 24, 2014. doi: 10.5410/wjcu.v3.i2.87
Published online Jul 24, 2014. doi: 10.5410/wjcu.v3.i2.87
Mesenchymal stem cells for kidney transplantation
Bron Lett, Kisha N Sivanathan, P Toby Coates, Central Northern Adelaide Renal and Transplantation Service, University of Adelaide, Royal Adelaide Hospital, Mawson Lakes, Adelaide 5000, South Australia, Australia
Author contributions: Lett B and Sivanathan KN written and edited the paper; Coates PT edited and supervised the paper.
Correspondence to: P Toby Coates, Professor, Central Northern Adelaide Renal and Transplantation Service, University of Adelaide, Royal Adelaide Hospital, Room D9-20 Level 9, East Wing, North Terrace, Mawson Lakes, Adelaide 5000, South Australia, Australia. toby.coates@health.sa.gov.au
Telephone: +61-8822-20934 Fax: +61-8822-25097
Received: April 28, 2014
Revised: June 6, 2014
Accepted: June 27, 2014
Published online: July 24, 2014
Processing time: 82 Days and 6.7 Hours
Revised: June 6, 2014
Accepted: June 27, 2014
Published online: July 24, 2014
Processing time: 82 Days and 6.7 Hours
Core Tip
Core tip: This review summaries several of the most prominent cellular therapies currently being examined for use in immunosuppression. From the current evidence the reviewers make the argument that mesenchymal stem cells offer the best chance of a useful and functional cellular therapy for solid organ transplantation.